URGN 18.80 ▼ -2.94% Live Trading Data - Stocknear

UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
18.80
-0.57 (-2.94%)
At close: Sep 04, 2025, 3:59 PM
18.80
0.00%
After-hours: Sep 04, 2025, 07:17 PM EDT
-2.94%
Bid 18.2
Market Cap 869.77M
Revenue (ttm) 94.24M
Net Income (ttm) -154.97M
EPS (ttm) -3.01
PE Ratio (ttm) -6.25
Forward PE -18.81
Analyst Buy
Ask 19.5
Volume 1,873,253
Avg. Volume (20D) 2,577,532
Open 19.35
Previous Close 19.37
Day's Range 18.18 - 19.48
52-Week Range 3.42 - 21.02
Beta 1.13

About URGN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol URGN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for URGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

UroGen Pharma Ltd. is scheduled to release its earnings on Nov 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+8.57%
UroGen Pharma shares are trading higher after Gugg... Unlock content with Pro Subscription
2 months ago
+51.78%
UroGen Pharma shares are trading higher after the FDA approved ZUSDURI for intravesical solution a the first and only medication for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.